Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study)

Introduction
In locally recurrent rectal cancer (LRRC), surgery is a standard treatment for resectable disease. However, short-term and long-term outcomes are unsatisfactory due to the invasive nature of surgical procedures and the high proportion of local recurrence. Consequently, the identification of reliable prognostic and predictive biomarkers to guide treatment decisions may improve outcomes. The presence of circulating tumour DNA (ctDNA) in plasma after surgery may signify the presence of minimal residual disease (MRD) in various cancers. Therefore, we have launched a multi-institutional prospective observational study of ctDNA for MRD detection in conjunction with JCOG1801, a randomised, controlled phase III trial evaluating the efficacy of preoperative chemoradiotherapy (pre-CRT) compared with up-front surgery for LRRC (jRCTs031190076, NCT04288999).

Methods and analysis
JCOG1801A1 is the first correlative study that assesses ctDNA in LRRC patients enrolled in JCOG1801. Patients randomised to up-front surgery will provide whole blood samples at three time points (prior to surgery, after surgery and after postoperative chemotherapy); those to pre-CRT will provide at five time points (prior to pre-CRT, after pre-CRT, prior to surgery, after surgery and after postoperative chemotherapy). Cell-free DNA will be extracted from plasma and analysed by Guardant Reveal, a tumour tissue–agnostic assay that assesses both genomic alterations and methylation patterns to determine the presence or absence of ctDNA. We will compare the prognosis and treatment response of patients according to their ctDNA status after surgery and at other time points.

Ethics and dissemination
The study protocol received approval from the Institutional Review Board of National Cancer Center Hospital East on behalf of the participating institutions in February 2023. The study is conducted in accordance with the precepts established in the Declaration of Helsinki and Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Written informed consent will be obtained from all eligible patients prior to registration.

Leggi
Agosto 2023

Abstract 9511: Sex Difference of Fibrous Cap Collagen Content in Patients With Coronary Artery Disease: An Intravascular Polarimetry Study

Circulation, Volume 146, Issue Suppl_1, Page A9511-A9511, November 8, 2022. Introduction:Intracoronary optical coherence tomography (OCT) polarimetry (OCT-polarimetry) enables to provide polarization properties (birefringence and depolarization) of the tissues in the coronary arterial wall together with coronary plaque microstructures. Collagen and smooth muscle cells exhibit birefringence, while depolarization is increased by the presence of macrophages and lipid components.Hypothesis:We hypothesized that there exists sex difference in collagen content of coronary plaques by measuring polarization properties of the coronary arterial walls.Methods:We analyzed 41 coronary lesions imaged with intracoronary OCT-polarimetry in 38 patients with CAD (ACS, n = 24 and chronic CAD, n = 14). Conventional OCT analysis included lesion-level qualitative analysis (fibrous cap thickness, presence of plaque rupture, macrophages, thrombus, layered plaque, cholesterol crystals) and quantitative analysis (lipid-burden index, calcium arc and length, and vessel lumen area). Polarimetric analysis was performed on OCT cross-sectional images with the thinnest fibrous cap of the lesion, blinded to the conventional OCT analysis results. The measurements were compared between male (n = 27) and female (n =11) using a generalized linear model with generalized estimating equations.Results:In this study population, ACS was more frequently observed in female patients compared to male patients (91% v.s. 52%, p

Leggi
Ottobre 2022